Max Towers Private Limited/Pharmax Corporation Limited Sustainability Profile
Max Towers Private Limited, also known as Pharmax Corporation Limited, is a prominent player in the pharmaceutical industry, headquartered in India. Established in [year founded], the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, catering to both domestic and international markets. With a focus on innovative formulations and a diverse portfolio, Max Towers excels in areas such as generic medicines, active pharmaceutical ingredients (APIs), and specialty pharmaceuticals. Their commitment to quality and compliance has positioned them as a trusted name in the industry, earning notable achievements and certifications. Operating primarily in India and expanding into key global markets, Max Towers continues to enhance its market presence through strategic partnerships and a robust supply chain. Their unique approach to product development and dedication to excellence sets them apart in a competitive landscape.
DitchCarbon Score
How does Max Towers Private Limited/Pharmax Corporation Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Max Towers Private Limited/Pharmax Corporation Limited's score of 5 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Max Towers Private Limited/Pharmax Corporation Limited, headquartered in India, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Max Estates Limited, which may influence its climate commitments and performance metrics. As of now, there are no documented reduction targets or climate pledges from Max Towers Private Limited/Pharmax Corporation Limited. The lack of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the context of the industry, it is essential for companies like Max Towers Private Limited/Pharmax Corporation Limited to establish clear carbon reduction targets and commitments to align with global climate goals. This could include adopting frameworks such as the Science Based Targets initiative (SBTi) or participating in initiatives like the Carbon Disclosure Project (CDP) to enhance transparency and accountability in their climate actions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 533,000,000 | 000,000 | 000,000 | 00,000 |
| Scope 2 | - | 000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - |
How Carbon Intensive is Max Towers Private Limited/Pharmax Corporation Limited's Industry?
How Carbon Intensive is Max Towers Private Limited/Pharmax Corporation Limited's Location?
Max Towers Private Limited/Pharmax Corporation Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Max Towers Private Limited/Pharmax Corporation Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
